Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Acquisition to Pay Record Fine for Mislabeling Products

By Eric Volkman - Updated Jan 30, 2020 at 11:10PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In a settlement, Cura Partners will fork over $110,000 to Oregon's cannabis regulator.

Cura Partners, a company that agreed to be acquired by Curaleaf (CURLF -0.39%), has been fined for mislabeling some of its products.

Cura Partners, which bills itself as the "largest cannabis oil company in Oregon and California," reached a settlement with the Oregon Liquor Control Commission (OLCC) on the matter. In the arrangement, Cura Partners is admitting that it mislabeled 186,152 units of its product. In numerous cases, the company apparently did not state the presence of botanical terpenes or MCT oil, ingredients used in vape products.

A vape pen next to marijuana leaves.

Image source: Getty Images.

In its marketing, Cura Partners at times claimed that different ingredients considered more preferential were used in its products.

For its oversights, Cura Partners will pay a fine of $110,000, a record in the history of the OLCC. The regulator said it wasn't apparent that the company's transgressions presented a health risk to users, so it did not mandate a halt in sales of the affected products.

The Portland Business Journal quoted from a letter it obtained written by a Cura Partners lawyer. The lawyer blamed "a communication problem," likely stemming from one or more employees, for the mistakes.

Neither Cura Partners nor Curaleaf, a popular marijuana stock, has yet officially commented on the settlement.

Despite the financial hit, the settlement could end up being good news for both. Curaleaf recently said that the long-gestating Cura Partners acquisition should close by Feb. 1, citing the transfer of Cura Partners' Oregon license. It's speculated that the settlement will go some way toward making that happen.

Curaleaf's stock closed up by nearly 6% on Thursday.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$5.05 (-0.39%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.